Literature DB >> 21197202

Immunohistochemical expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 in canine simple mammary gland adenocarcinomas.

Ahmad N Al-Dissi1, Deborah M Haines, Baljit Singh, Beverly A Kidney.   

Abstract

The expression of 5 markers associated with angiogenesis, proliferation, and apoptosis was studied in 26 canine simple mammary gland adenocarcinomas (SMGAs). The adenocarcinomas were graded histologically, and tissue sections were immunohistochemically stained for the expression of vascular endothelial growth factor (VEGF), VEGF receptor-2 (VEGFR-2), intra-tumor microvessel density, and tumor proliferation (PI) using antibodies against VEGF, VEGFR-2, von Willebrand factor, and Ki-67 antigen, respectively. Apoptotic indices (AI) were determined by an apoptosis assay. Markers VEGF and VEGFR-2 were detected in 96% and 100% of SMGAs, respectively. A high correlation between histologic grade and PI (r = 0.73), a moderate correlation between VEGF and histologic grade (r = 0.33), and between VEGF and PI (r = 0.42) were found. There was a significant difference in median PI among the 3 histologic grade groups (r < 0.05). Vascular endothelial growth factor may stimulate tumor cell proliferation through an autocrine loop, since VEGF and VEGFR-2 were expressed in most tumors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21197202      PMCID: PMC2942048     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


  52 in total

1.  Apoptotic and proliferation indexes in canine lymphoma.

Authors:  B S Phillips; P H Kass; D K Naydan; M D Winthrop; S M Griffey; B R Madewell
Journal:  J Vet Diagn Invest       Date:  2000-03       Impact factor: 1.279

2.  Histochemical study of vascular endothelial growth factor in squamous cell carcinoma of the esophagus.

Authors:  N Koide; A Nishio; T Kono; K Yazawa; J Igarashi; H Watanabe; Y Nimura; K Hanazaki; W Adachi; J Amano
Journal:  Hepatogastroenterology       Date:  1999 Mar-Apr

3.  Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium.

Authors:  G H Fong; J Rossant; M Gertsenstein; M L Breitman
Journal:  Nature       Date:  1995-07-06       Impact factor: 49.962

4.  Microvessel quantitation and prognosis in invasive breast carcinoma.

Authors:  S Bosari; A K Lee; R A DeLellis; B D Wiley; G J Heatley; M L Silverman
Journal:  Hum Pathol       Date:  1992-07       Impact factor: 3.466

5.  Immunohistochemical expression of vascular endothelial growth factor and vascular endothelial growth factor receptor associated with tumor cell proliferation in canine cutaneous squamous cell carcinomas and trichoepitheliomas.

Authors:  A N Al-Dissi; D M Haines; B Singh; B A Kidney
Journal:  Vet Pathol       Date:  2007-11       Impact factor: 2.221

6.  Validation of the use of proliferation markers in canine neoplastic and non-neoplastic tissues: comparison of KI-67 and proliferating cell nuclear antigen (PCNA) expression versus in vivo bromodeoxyuridine labelling by immunohistochemistry.

Authors:  A Zacchetti; E van Garderen; E Teske; H Nederbragt; J H Dierendonck; G R Rutteman
Journal:  APMIS       Date:  2003-03       Impact factor: 3.205

Review 7.  Angiogenesis in cancer, vascular, rheumatoid and other disease.

Authors:  J Folkman
Journal:  Nat Med       Date:  1995-01       Impact factor: 53.440

8.  Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours.

Authors:  V W Li; R D Folkerth; H Watanabe; C Yu; M Rupnick; P Barnes; R M Scott; P M Black; S E Sallan; J Folkman
Journal:  Lancet       Date:  1994-07-09       Impact factor: 79.321

9.  Tumor angiogenesis and rectal carcinoma.

Authors:  T J Saclarides; N J Speziale; E Drab; D J Szeluga; D B Rubin
Journal:  Dis Colon Rectum       Date:  1994-09       Impact factor: 4.585

10.  Prognostic significance of microvessel density and other variables in Japanese and British patients with primary invasive breast cancer.

Authors:  T Kato; G Steers; L Campo; H Roberts; R D Leek; H Turley; T Kimura; S Kameoka; T Nishikawa; M Kobayashi; A L Harris; K C Gatter; F Pezzella
Journal:  Br J Cancer       Date:  2007-10-09       Impact factor: 7.640

View more
  14 in total

1.  Effects of recombinant human endostatin and its synergy with cisplatin on circulating endothelial cells and tumor vascular normalization in A549 xenograft murine model.

Authors:  Na Li; Dawei Zheng; Xiyin Wei; Ziliang Jin; Cuicui Zhang; Kai Li
Journal:  J Cancer Res Clin Oncol       Date:  2012-03-10       Impact factor: 4.553

2.  Peripheral blood biomarkers of solid tumor angiogenesis in dogs: a polychromatic flow cytometry pilot study.

Authors:  R Timothy Bentley; Julie A Mund; Karen E Pollok; Michael O Childress; Jamie Case
Journal:  Vet J       Date:  2012-10-12       Impact factor: 2.688

Review 3.  Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients.

Authors:  Sandeep S Patil; Ivaylo Gentschev; Ingo Nolte; Gregory Ogilvie; Aladar A Szalay
Journal:  J Transl Med       Date:  2012-01-04       Impact factor: 5.531

4.  Tarantula cubensis extract alters the degree of apoptosis and mitosis in canine mammary adenocarcinomas.

Authors:  Nilgun Gultiken; Tolga Guvenc; Duygu Kaya; Ali Reha Agaoglu; Serhan Serhat Ay; Ibrahim Kucukaslan; Birten Emre; Murat Findik; Sabine Schäfer-Somi; Selim Aslan
Journal:  J Vet Sci       Date:  2014-12-24       Impact factor: 1.672

Review 5.  Angiogenesis in spontaneous tumors and implications for comparative tumor biology.

Authors:  C Benazzi; A Al-Dissi; C H Chau; W D Figg; G Sarli; J T de Oliveira; F Gärtner
Journal:  ScientificWorldJournal       Date:  2014-01-19

6.  Immunogenicity and safety of xenogeneic vascular endothelial growth factor receptor-2 DNA vaccination in mice and dogs.

Authors:  Sofie Denies; Laetitia Cicchelero; Ingeborgh Polis; Niek N Sanders
Journal:  Oncotarget       Date:  2016-03-08

7.  Prostatic hyperplasia: Vascularization, hemodynamic and hormonal analysis of dogs treated with finasteride or orchiectomy.

Authors:  Daniel S R Angrimani; Maria Claudia P Francischini; Maíra M Brito; Camila I Vannucchi
Journal:  PLoS One       Date:  2020-06-25       Impact factor: 3.240

8.  Interleukin-6, vascular endothelial growth factor and transforming growth factor beta 1 in canine steroid responsive meningitis-arteritis.

Authors:  Arianna Maiolini; Meike Otten; Marion Hewicker-Trautwein; Regina Carlson; Andrea Tipold
Journal:  BMC Vet Res       Date:  2013-02-04       Impact factor: 2.741

9.  Identification of prognostic factors in canine mammary malignant tumours: a multivariable survival study.

Authors:  Andreia A Santos; Célia C Lopes; Jorge R Ribeiro; Liliana R Martins; Joana C Santos; Irina F Amorim; Fátima Gärtner; Augusto J Matos
Journal:  BMC Vet Res       Date:  2013-01-04       Impact factor: 2.741

10.  Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling.

Authors:  Xunian Zhou; Grace Gar-Lee Yue; Minghua Liu; Zhili Zuo; Julia Kin-Ming Lee; Mingyue Li; Stephen Kwok-Wing Tsui; Kwok-Pui Fung; Handong Sun; Jianxin Pu; Clara Bik-San Lau
Journal:  Oncotarget       Date:  2016-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.